nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—Function kidney decreased—Metformin—polycystic ovary syndrome	0.0193	0.0831	CcSEcCtD
Tacrolimus—ABCA5—adrenal cortex—polycystic ovary syndrome	0.0141	0.048	CbGeAlD
Tacrolimus—ABCA5—endometrium—polycystic ovary syndrome	0.0126	0.0428	CbGeAlD
Tacrolimus—ABCA5—pituitary gland—polycystic ovary syndrome	0.0114	0.0388	CbGeAlD
Tacrolimus—ABCA5—adipose tissue—polycystic ovary syndrome	0.0114	0.0386	CbGeAlD
Tacrolimus—ABCA5—adrenal gland—polycystic ovary syndrome	0.0102	0.0346	CbGeAlD
Tacrolimus—Tooth abscess—Metformin—polycystic ovary syndrome	0.0101	0.0434	CcSEcCtD
Tacrolimus—PPP3CA—adrenal cortex—polycystic ovary syndrome	0.00955	0.0324	CbGeAlD
Tacrolimus—ABCA5—female gonad—polycystic ovary syndrome	0.00952	0.0323	CbGeAlD
Tacrolimus—ABCA5—vagina—polycystic ovary syndrome	0.00946	0.0321	CbGeAlD
Tacrolimus—ABCA5—endocrine gland—polycystic ovary syndrome	0.00885	0.03	CbGeAlD
Tacrolimus—Abdominal bloating—Metformin—polycystic ovary syndrome	0.00884	0.0381	CcSEcCtD
Tacrolimus—MTOR—embryo—polycystic ovary syndrome	0.00861	0.0292	CbGeAlD
Tacrolimus—PPP3CA—endometrium—polycystic ovary syndrome	0.00853	0.0289	CbGeAlD
Tacrolimus—PPP3CA—uterus—polycystic ovary syndrome	0.00786	0.0267	CbGeAlD
Tacrolimus—CYP3A4—urine—polycystic ovary syndrome	0.00783	0.0266	CbGeAlD
Tacrolimus—PPP3CA—pituitary gland—polycystic ovary syndrome	0.00772	0.0262	CbGeAlD
Tacrolimus—PPP3CA—adipose tissue—polycystic ovary syndrome	0.00769	0.0261	CbGeAlD
Tacrolimus—Acidosis—Metformin—polycystic ovary syndrome	0.0076	0.0328	CcSEcCtD
Tacrolimus—Loose stools—Metformin—polycystic ovary syndrome	0.0076	0.0328	CcSEcCtD
Tacrolimus—PPP3CA—adrenal gland—polycystic ovary syndrome	0.0069	0.0234	CbGeAlD
Tacrolimus—Respiratory distress—Metformin—polycystic ovary syndrome	0.00663	0.0285	CcSEcCtD
Tacrolimus—Nail disorder—Metformin—polycystic ovary syndrome	0.00649	0.028	CcSEcCtD
Tacrolimus—PPP3CA—female gonad—polycystic ovary syndrome	0.00643	0.0218	CbGeAlD
Tacrolimus—PPP3CA—vagina—polycystic ovary syndrome	0.00639	0.0217	CbGeAlD
Tacrolimus—FKBP1A—adrenal cortex—polycystic ovary syndrome	0.00635	0.0215	CbGeAlD
Tacrolimus—MTOR—endometrium—polycystic ovary syndrome	0.0063	0.0214	CbGeAlD
Tacrolimus—PPP3CA—endocrine gland—polycystic ovary syndrome	0.00598	0.0203	CbGeAlD
Tacrolimus—MTOR—uterus—polycystic ovary syndrome	0.00581	0.0197	CbGeAlD
Tacrolimus—MTOR—pituitary gland—polycystic ovary syndrome	0.0057	0.0193	CbGeAlD
Tacrolimus—MTOR—adipose tissue—polycystic ovary syndrome	0.00568	0.0193	CbGeAlD
Tacrolimus—FKBP1A—endometrium—polycystic ovary syndrome	0.00567	0.0192	CbGeAlD
Tacrolimus—FKBP1A—uterus—polycystic ovary syndrome	0.00522	0.0177	CbGeAlD
Tacrolimus—FKBP1A—pituitary gland—polycystic ovary syndrome	0.00513	0.0174	CbGeAlD
Tacrolimus—FKBP1A—adipose tissue—polycystic ovary syndrome	0.00511	0.0173	CbGeAlD
Tacrolimus—MTOR—adrenal gland—polycystic ovary syndrome	0.00509	0.0173	CbGeAlD
Tacrolimus—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00492	0.0167	CbGeAlD
Tacrolimus—Chest discomfort—Metformin—polycystic ovary syndrome	0.00476	0.0205	CcSEcCtD
Tacrolimus—Accidental injury—Metformin—polycystic ovary syndrome	0.00476	0.0205	CcSEcCtD
Tacrolimus—MTOR—female gonad—polycystic ovary syndrome	0.00475	0.0161	CbGeAlD
Tacrolimus—MTOR—vagina—polycystic ovary syndrome	0.00472	0.016	CbGeAlD
Tacrolimus—FKBP1A—adrenal gland—polycystic ovary syndrome	0.00458	0.0155	CbGeAlD
Tacrolimus—ORM1—endometrium—polycystic ovary syndrome	0.00444	0.0151	CbGeAlD
Tacrolimus—MTOR—endocrine gland—polycystic ovary syndrome	0.00442	0.015	CbGeAlD
Tacrolimus—FKBP1A—female gonad—polycystic ovary syndrome	0.00427	0.0145	CbGeAlD
Tacrolimus—FKBP1A—vagina—polycystic ovary syndrome	0.00425	0.0144	CbGeAlD
Tacrolimus—FKBP1A—endocrine gland—polycystic ovary syndrome	0.00397	0.0135	CbGeAlD
Tacrolimus—Neuropathy—Metformin—polycystic ovary syndrome	0.00395	0.017	CcSEcCtD
Tacrolimus—Ear pain—Metformin—polycystic ovary syndrome	0.00358	0.0154	CcSEcCtD
Tacrolimus—Nasal congestion—Metformin—polycystic ovary syndrome	0.00335	0.0145	CcSEcCtD
Tacrolimus—Injury—Metformin—polycystic ovary syndrome	0.00332	0.0143	CcSEcCtD
Tacrolimus—Renal impairment—Metformin—polycystic ovary syndrome	0.00321	0.0138	CcSEcCtD
Tacrolimus—ALB—adrenal gland—polycystic ovary syndrome	0.00315	0.0107	CbGeAlD
Tacrolimus—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00313	0.0135	CcSEcCtD
Tacrolimus—ORM1—endocrine gland—polycystic ovary syndrome	0.00311	0.0106	CbGeAlD
Tacrolimus—Pain in extremity—Metformin—polycystic ovary syndrome	0.00306	0.0132	CcSEcCtD
Tacrolimus—Migraine—Metformin—polycystic ovary syndrome	0.00301	0.013	CcSEcCtD
Tacrolimus—Dehydration—Metformin—polycystic ovary syndrome	0.00284	0.0122	CcSEcCtD
Tacrolimus—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00282	0.0122	CcSEcCtD
Tacrolimus—Breast disorder—Metformin—polycystic ovary syndrome	0.00276	0.0119	CcSEcCtD
Tacrolimus—Cramp muscle—Metformin—polycystic ovary syndrome	0.00275	0.0119	CcSEcCtD
Tacrolimus—Abdominal distension—Metformin—polycystic ovary syndrome	0.00266	0.0115	CcSEcCtD
Tacrolimus—Influenza—Metformin—polycystic ovary syndrome	0.00264	0.0114	CcSEcCtD
Tacrolimus—Pancreatitis—Metformin—polycystic ovary syndrome	0.00259	0.0112	CcSEcCtD
Tacrolimus—Sweating increased—Metformin—polycystic ovary syndrome	0.00257	0.0111	CcSEcCtD
Tacrolimus—Angina pectoris—Metformin—polycystic ovary syndrome	0.00257	0.0111	CcSEcCtD
Tacrolimus—Neutropenia—Metformin—polycystic ovary syndrome	0.00247	0.0106	CcSEcCtD
Tacrolimus—Infestation—Metformin—polycystic ovary syndrome	0.00235	0.0101	CcSEcCtD
Tacrolimus—Infestation NOS—Metformin—polycystic ovary syndrome	0.00235	0.0101	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00231	0.00994	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00223	0.00959	CcSEcCtD
Tacrolimus—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00222	0.00755	CbGeAlD
Tacrolimus—Bradycardia—Metformin—polycystic ovary syndrome	0.00215	0.00927	CcSEcCtD
Tacrolimus—Rhinitis—Metformin—polycystic ovary syndrome	0.00212	0.00913	CcSEcCtD
Tacrolimus—Hepatitis—Metformin—polycystic ovary syndrome	0.00211	0.00911	CcSEcCtD
Tacrolimus—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0021	0.00906	CcSEcCtD
Tacrolimus—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00208	0.00897	CcSEcCtD
Tacrolimus—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00208	0.00895	CcSEcCtD
Tacrolimus—Eye disorder—Metformin—polycystic ovary syndrome	0.00198	0.00851	CcSEcCtD
Tacrolimus—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00196	0.00845	CcSEcCtD
Tacrolimus—Flushing—Metformin—polycystic ovary syndrome	0.00196	0.00845	CcSEcCtD
Tacrolimus—Angiopathy—Metformin—polycystic ovary syndrome	0.00192	0.00826	CcSEcCtD
Tacrolimus—Immune system disorder—Metformin—polycystic ovary syndrome	0.00191	0.00823	CcSEcCtD
Tacrolimus—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00191	0.00821	CcSEcCtD
Tacrolimus—Chills—Metformin—polycystic ovary syndrome	0.0019	0.00817	CcSEcCtD
Tacrolimus—CYP3A5—female gonad—polycystic ovary syndrome	0.00186	0.00631	CbGeAlD
Tacrolimus—CYP3A5—vagina—polycystic ovary syndrome	0.00185	0.00627	CbGeAlD
Tacrolimus—Malnutrition—Metformin—polycystic ovary syndrome	0.00184	0.00793	CcSEcCtD
Tacrolimus—Erythema—Metformin—polycystic ovary syndrome	0.00184	0.00793	CcSEcCtD
Tacrolimus—Flatulence—Metformin—polycystic ovary syndrome	0.00181	0.00781	CcSEcCtD
Tacrolimus—Dysgeusia—Metformin—polycystic ovary syndrome	0.0018	0.00776	CcSEcCtD
Tacrolimus—ABCB1—embryo—polycystic ovary syndrome	0.00179	0.00608	CbGeAlD
Tacrolimus—Muscle spasms—Metformin—polycystic ovary syndrome	0.00177	0.00762	CcSEcCtD
Tacrolimus—Vision blurred—Metformin—polycystic ovary syndrome	0.00173	0.00747	CcSEcCtD
Tacrolimus—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00173	0.00587	CbGeAlD
Tacrolimus—Tremor—Metformin—polycystic ovary syndrome	0.00172	0.00743	CcSEcCtD
Tacrolimus—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00171	0.00736	CcSEcCtD
Tacrolimus—Malaise—Metformin—polycystic ovary syndrome	0.00166	0.00715	CcSEcCtD
Tacrolimus—Syncope—Metformin—polycystic ovary syndrome	0.00165	0.00711	CcSEcCtD
Tacrolimus—Palpitations—Metformin—polycystic ovary syndrome	0.00163	0.00701	CcSEcCtD
Tacrolimus—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00162	0.00697	CcSEcCtD
Tacrolimus—Hypertension—Metformin—polycystic ovary syndrome	0.00159	0.00684	CcSEcCtD
Tacrolimus—Chest pain—Metformin—polycystic ovary syndrome	0.00157	0.00675	CcSEcCtD
Tacrolimus—Myalgia—Metformin—polycystic ovary syndrome	0.00157	0.00675	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00156	0.0067	CcSEcCtD
Tacrolimus—Discomfort—Metformin—polycystic ovary syndrome	0.00155	0.00667	CcSEcCtD
Tacrolimus—Oedema—Metformin—polycystic ovary syndrome	0.0015	0.00647	CcSEcCtD
Tacrolimus—Infection—Metformin—polycystic ovary syndrome	0.00149	0.00643	CcSEcCtD
Tacrolimus—Shock—Metformin—polycystic ovary syndrome	0.00148	0.00637	CcSEcCtD
Tacrolimus—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00147	0.00635	CcSEcCtD
Tacrolimus—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00147	0.00634	CcSEcCtD
Tacrolimus—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00147	0.00498	CbGeAlD
Tacrolimus—Skin disorder—Metformin—polycystic ovary syndrome	0.00146	0.00628	CcSEcCtD
Tacrolimus—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00145	0.00625	CcSEcCtD
Tacrolimus—Anorexia—Metformin—polycystic ovary syndrome	0.00143	0.00617	CcSEcCtD
Tacrolimus—Hypotension—Metformin—polycystic ovary syndrome	0.0014	0.00605	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00137	0.00589	CcSEcCtD
Tacrolimus—Paraesthesia—Metformin—polycystic ovary syndrome	0.00135	0.00581	CcSEcCtD
Tacrolimus—Dyspnoea—Metformin—polycystic ovary syndrome	0.00134	0.00577	CcSEcCtD
Tacrolimus—Somnolence—Metformin—polycystic ovary syndrome	0.00134	0.00575	CcSEcCtD
Tacrolimus—Dyspepsia—Metformin—polycystic ovary syndrome	0.00132	0.0057	CcSEcCtD
Tacrolimus—ABCB1—endometrium—polycystic ovary syndrome	0.00131	0.00445	CbGeAlD
Tacrolimus—Decreased appetite—Metformin—polycystic ovary syndrome	0.00131	0.00562	CcSEcCtD
Tacrolimus—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0013	0.0044	CbGeAlD
Tacrolimus—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.0013	0.00559	CcSEcCtD
Tacrolimus—Fatigue—Metformin—polycystic ovary syndrome	0.00129	0.00558	CcSEcCtD
Tacrolimus—Constipation—Metformin—polycystic ovary syndrome	0.00128	0.00553	CcSEcCtD
Tacrolimus—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00124	0.00533	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00123	0.00529	CcSEcCtD
Tacrolimus—ABCB1—uterus—polycystic ovary syndrome	0.00121	0.0041	CbGeAlD
Tacrolimus—Urticaria—Metformin—polycystic ovary syndrome	0.00119	0.00514	CcSEcCtD
Tacrolimus—Abdominal pain—Metformin—polycystic ovary syndrome	0.00119	0.00511	CcSEcCtD
Tacrolimus—ABCB1—pituitary gland—polycystic ovary syndrome	0.00119	0.00402	CbGeAlD
Tacrolimus—ABCB1—adipose tissue—polycystic ovary syndrome	0.00118	0.00401	CbGeAlD
Tacrolimus—Asthenia—Metformin—polycystic ovary syndrome	0.00108	0.00464	CcSEcCtD
Tacrolimus—Pruritus—Metformin—polycystic ovary syndrome	0.00106	0.00458	CcSEcCtD
Tacrolimus—ABCB1—adrenal gland—polycystic ovary syndrome	0.00106	0.0036	CbGeAlD
Tacrolimus—Diarrhoea—Metformin—polycystic ovary syndrome	0.00103	0.00443	CcSEcCtD
Tacrolimus—Dizziness—Metformin—polycystic ovary syndrome	0.000993	0.00428	CcSEcCtD
Tacrolimus—ABCB1—female gonad—polycystic ovary syndrome	0.000988	0.00335	CbGeAlD
Tacrolimus—ABCB1—vagina—polycystic ovary syndrome	0.000982	0.00333	CbGeAlD
Tacrolimus—Vomiting—Metformin—polycystic ovary syndrome	0.000955	0.00411	CcSEcCtD
Tacrolimus—Rash—Metformin—polycystic ovary syndrome	0.000947	0.00408	CcSEcCtD
Tacrolimus—Dermatitis—Metformin—polycystic ovary syndrome	0.000946	0.00408	CcSEcCtD
Tacrolimus—Headache—Metformin—polycystic ovary syndrome	0.000941	0.00405	CcSEcCtD
Tacrolimus—ABCB1—endocrine gland—polycystic ovary syndrome	0.000919	0.00312	CbGeAlD
Tacrolimus—Nausea—Metformin—polycystic ovary syndrome	0.000892	0.00384	CcSEcCtD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	8.53e-05	0.00018	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	8.51e-05	0.00018	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IRS1—polycystic ovary syndrome	8.48e-05	0.000179	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SCT—polycystic ovary syndrome	8.45e-05	0.000179	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IRS2—polycystic ovary syndrome	8.39e-05	0.000177	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	8.32e-05	0.000176	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	8.32e-05	0.000176	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	8.32e-05	0.000176	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	8.31e-05	0.000176	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—LEP—polycystic ovary syndrome	8.21e-05	0.000174	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	8.19e-05	0.000173	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—IRS1—polycystic ovary syndrome	8.15e-05	0.000172	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—polycystic ovary syndrome	8.14e-05	0.000172	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—GNAS—polycystic ovary syndrome	8.12e-05	0.000172	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IRS1—polycystic ovary syndrome	8.11e-05	0.000171	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TAB1—polycystic ovary syndrome	8.11e-05	0.000171	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	8.09e-05	0.000171	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	8.06e-05	0.00017	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	8.06e-05	0.00017	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PRL—polycystic ovary syndrome	8.03e-05	0.00017	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	8.03e-05	0.00017	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	7.93e-05	0.000168	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGF18—polycystic ovary syndrome	7.92e-05	0.000167	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TCF7L2—polycystic ovary syndrome	7.91e-05	0.000167	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	7.9e-05	0.000167	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	7.9e-05	0.000167	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	7.9e-05	0.000167	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RBP4—polycystic ovary syndrome	7.86e-05	0.000166	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—AKT2—polycystic ovary syndrome	7.85e-05	0.000166	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	7.85e-05	0.000166	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SLC2A4—polycystic ovary syndrome	7.78e-05	0.000164	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—INS—polycystic ovary syndrome	7.77e-05	0.000164	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.74e-05	0.000164	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	7.65e-05	0.000162	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.6e-05	0.000161	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	7.56e-05	0.00016	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	7.55e-05	0.00016	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—AKT2—polycystic ovary syndrome	7.54e-05	0.000159	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—AKT2—polycystic ovary syndrome	7.51e-05	0.000159	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.47e-05	0.000158	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PRL—polycystic ovary syndrome	7.42e-05	0.000157	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	7.41e-05	0.000157	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—YAP1—polycystic ovary syndrome	7.33e-05	0.000155	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IRS1—polycystic ovary syndrome	7.33e-05	0.000155	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GAB1—polycystic ovary syndrome	7.23e-05	0.000153	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	7.18e-05	0.000152	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	7.16e-05	0.000151	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	7.15e-05	0.000151	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—SERPINE1—polycystic ovary syndrome	7.14e-05	0.000151	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	7.07e-05	0.000149	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—POMC—polycystic ovary syndrome	7.05e-05	0.000149	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	7.04e-05	0.000149	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—INS—polycystic ovary syndrome	7.02e-05	0.000148	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	6.92e-05	0.000146	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—INSR—polycystic ovary syndrome	6.92e-05	0.000146	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—BCL2—polycystic ovary syndrome	6.86e-05	0.000145	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—STAR—polycystic ovary syndrome	6.83e-05	0.000144	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	6.83e-05	0.000144	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IGF1—polycystic ovary syndrome	6.79e-05	0.000143	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AKT2—polycystic ovary syndrome	6.78e-05	0.000143	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL18—polycystic ovary syndrome	6.76e-05	0.000143	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	6.75e-05	0.000143	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	6.75e-05	0.000143	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	6.73e-05	0.000142	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	6.65e-05	0.000141	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—polycystic ovary syndrome	6.64e-05	0.00014	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—GNAS—polycystic ovary syndrome	6.62e-05	0.00014	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	6.62e-05	0.00014	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NRG1—polycystic ovary syndrome	6.61e-05	0.00014	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.57e-05	0.000139	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	6.57e-05	0.000139	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	6.54e-05	0.000138	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.51e-05	0.000138	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.47e-05	0.000137	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.44e-05	0.000136	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PGR—polycystic ovary syndrome	6.4e-05	0.000135	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—LEP—polycystic ovary syndrome	6.37e-05	0.000135	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	6.28e-05	0.000133	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—polycystic ovary syndrome	6.22e-05	0.000132	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NCOR1—polycystic ovary syndrome	6.22e-05	0.000131	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	6.2e-05	0.000131	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	6.16e-05	0.00013	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	6.16e-05	0.00013	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	6.15e-05	0.00013	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	6.11e-05	0.000129	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NRG1—polycystic ovary syndrome	6.1e-05	0.000129	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HMMR—polycystic ovary syndrome	6.09e-05	0.000129	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	6.01e-05	0.000127	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—STAR—polycystic ovary syndrome	5.99e-05	0.000127	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.99e-05	0.000127	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GHRL—polycystic ovary syndrome	5.95e-05	0.000126	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PLAT—polycystic ovary syndrome	5.95e-05	0.000126	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	5.82e-05	0.000123	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	5.81e-05	0.000123	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.74e-05	0.000121	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.73e-05	0.000121	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	5.72e-05	0.000121	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	5.71e-05	0.000121	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.68e-05	0.00012	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ATF1—polycystic ovary syndrome	5.68e-05	0.00012	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IRS2—polycystic ovary syndrome	5.66e-05	0.00012	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—polycystic ovary syndrome	5.66e-05	0.00012	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.54e-05	0.000117	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MTHFR—polycystic ovary syndrome	5.49e-05	0.000116	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—POMC—polycystic ovary syndrome	5.47e-05	0.000116	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.44e-05	0.000115	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—INS—polycystic ovary syndrome	5.44e-05	0.000115	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	5.43e-05	0.000115	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	5.36e-05	0.000113	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	5.35e-05	0.000113	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	5.34e-05	0.000113	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—LHB—polycystic ovary syndrome	5.3e-05	0.000112	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TH—polycystic ovary syndrome	5.28e-05	0.000112	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.26e-05	0.000111	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.26e-05	0.000111	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NGFR—polycystic ovary syndrome	5.24e-05	0.000111	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IRS2—polycystic ovary syndrome	5.23e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRL—polycystic ovary syndrome	5.19e-05	0.00011	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	5.19e-05	0.00011	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—polycystic ovary syndrome	5.19e-05	0.00011	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	5.18e-05	0.000109	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	5.14e-05	0.000109	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	5.09e-05	0.000108	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.02e-05	0.000106	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	5.02e-05	0.000106	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	5e-05	0.000106	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5e-05	0.000106	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IRS1—polycystic ovary syndrome	4.94e-05	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.93e-05	0.000104	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	4.87e-05	0.000103	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	4.87e-05	0.000103	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	4.83e-05	0.000102	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	4.81e-05	0.000102	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	4.75e-05	0.0001	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—polycystic ovary syndrome	4.74e-05	0.0001	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LHB—polycystic ovary syndrome	4.64e-05	9.81e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	4.62e-05	9.76e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AKT2—polycystic ovary syndrome	4.57e-05	9.67e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GNAS—polycystic ovary syndrome	4.57e-05	9.66e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IRS1—polycystic ovary syndrome	4.56e-05	9.64e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	4.54e-05	9.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	4.48e-05	9.48e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—RRM2—polycystic ovary syndrome	4.47e-05	9.45e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.43e-05	9.37e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	4.41e-05	9.33e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	4.39e-05	9.29e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—polycystic ovary syndrome	4.38e-05	9.25e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—INS—polycystic ovary syndrome	4.37e-05	9.23e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.35e-05	9.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	4.31e-05	9.12e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—YAP1—polycystic ovary syndrome	4.31e-05	9.11e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF1—polycystic ovary syndrome	4.29e-05	9.07e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—AKT2—polycystic ovary syndrome	4.29e-05	9.06e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NRG1—polycystic ovary syndrome	4.27e-05	9.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—AKT2—polycystic ovary syndrome	4.22e-05	8.93e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NAMPT—polycystic ovary syndrome	4.14e-05	8.75e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.12e-05	8.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	4.11e-05	8.68e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	4.09e-05	8.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	4.08e-05	8.62e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	4.07e-05	8.61e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.06e-05	8.58e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	4.04e-05	8.55e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—SERPINE1—polycystic ovary syndrome	4.01e-05	8.48e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—BCL2—polycystic ovary syndrome	4e-05	8.44e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	3.92e-05	8.28e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	3.89e-05	8.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	3.87e-05	8.17e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	3.86e-05	8.16e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TH—polycystic ovary syndrome	3.82e-05	8.07e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	3.8e-05	8.03e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	3.78e-05	7.98e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	3.71e-05	7.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	3.69e-05	7.8e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IRS2—polycystic ovary syndrome	3.66e-05	7.74e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	3.63e-05	7.67e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	3.63e-05	7.67e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	3.58e-05	7.57e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LEP—polycystic ovary syndrome	3.58e-05	7.57e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—polycystic ovary syndrome	3.55e-05	7.5e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	3.49e-05	7.38e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.44e-05	7.26e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—polycystic ovary syndrome	3.39e-05	7.17e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	3.38e-05	7.15e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	3.33e-05	7.04e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TH—polycystic ovary syndrome	3.29e-05	6.95e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	3.29e-05	6.95e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	3.2e-05	6.76e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IRS1—polycystic ovary syndrome	3.19e-05	6.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.14e-05	6.63e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	3.12e-05	6.59e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—POMC—polycystic ovary syndrome	3.08e-05	6.5e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—polycystic ovary syndrome	3.07e-05	6.48e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—INS—polycystic ovary syndrome	3.06e-05	6.47e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	3.01e-05	6.36e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	2.97e-05	6.28e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1—polycystic ovary syndrome	2.96e-05	6.25e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AKT2—polycystic ovary syndrome	2.96e-05	6.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	2.94e-05	6.22e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	2.9e-05	6.14e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—INS—polycystic ovary syndrome	2.89e-05	6.1e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TH—polycystic ovary syndrome	2.88e-05	6.09e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	2.86e-05	6.05e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	2.82e-05	5.95e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.81e-05	5.94e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	2.8e-05	5.93e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	2.8e-05	5.92e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	2.8e-05	5.91e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.71e-05	5.72e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GNAS—polycystic ovary syndrome	2.68e-05	5.68e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	2.64e-05	5.57e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	2.62e-05	5.55e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NCOR1—polycystic ovary syndrome	2.56e-05	5.41e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.49e-05	5.27e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	2.42e-05	5.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.41e-05	5.1e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.38e-05	5.02e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.35e-05	4.97e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.33e-05	4.92e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—polycystic ovary syndrome	2.26e-05	4.78e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.24e-05	4.74e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.23e-05	4.72e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.21e-05	4.67e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.13e-05	4.5e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.12e-05	4.49e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.1e-05	4.44e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.09e-05	4.41e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.08e-05	4.41e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—polycystic ovary syndrome	2.07e-05	4.37e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.05e-05	4.34e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.98e-05	4.19e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.93e-05	4.09e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—polycystic ovary syndrome	1.91e-05	4.04e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PPARG—polycystic ovary syndrome	1.83e-05	3.87e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—POMC—polycystic ovary syndrome	1.81e-05	3.82e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—INS—polycystic ovary syndrome	1.8e-05	3.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.78e-05	3.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.73e-05	3.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.62e-05	3.43e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.61e-05	3.39e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.58e-05	3.35e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.58e-05	3.33e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.45e-05	3.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.38e-05	2.92e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—polycystic ovary syndrome	1.34e-05	2.83e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.31e-05	2.77e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.22e-05	2.58e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	9.89e-06	2.09e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	9.76e-06	2.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—INS—polycystic ovary syndrome	9.7e-06	2.05e-05	CbGpPWpGaD
